Interactive Digital Inhaler Guides Pulmonary Care
By HospiMedica International staff writers Posted on 05 Feb 2020 |
Image: The CapMedic inhaler cap and smartphone app (Photo courtesy of Cognita Labs)
The fusion of digital technology and a traditional metered dose inhaler (MDI) provides users with interactive cues that optimize respiratory therapy.
The Cognita Labs (Santa Ana, CA, USA) CapMedic device is a wireless AI-powered sensor cap that can be attached to any MDI, in order to provide precisely timed, step-by-step interactive cues that break down complex inhalation steps. Examples of such audiovisual cues include the correct coordination of deep inhalation, and even easy-to-forget preliminary steps such as shaking the MDI before use and maintaining it in an upright position. Indications for use include asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary conditions.
CapMedic is also a dual-purpose device, thanks to an in-built spirometer that empowers users to track the progression of their lung health by measuring lung parameters such as forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF). Medication and lung function data can be transferred to the CapMedic smartphone app, empowering patients to actively engage in managing their condition and enabling remote patient monitoring (RPM) for providers.
“Decades of studies have shown that almost 90% of patients are unable to use MDIs correctly, a result of their complex, multi-step usage requirements. The Cognita team has conducted drug deposition studies showing a tenfold improvement in the delivery of medication,” said Rajoshi Biswas, PhD, chief scientific officer and co-founder of Cognita Labs. “Our goal with CapMedic is to make inhalers fun and easy to use, while allowing patients to build good inhaler use habits and better manage their respiratory conditions. An effective daily dose means patients are more likely to avoid costly, life-threatening hospitalizations.”
“We've never really known if our patients are getting the medication they need at home because many of them struggle to use inhalers correctly. CapMedic brings us the data we didn't have before,” said pediatric pulmonologist Chris Landon, MD, of the Pediatric Diagnostic Center (Ventura, CA, USA). “We have seen our little patients, and our big ones, loving the sounds and lights of CapMedic while improving their technique. Parents synchronize lung function and medication data with their smartphone app, which gives us a snapshot of their compliance remotely.”
Spirometry is the most common pulmonary function test that measures lung function, specifically the volume and/or flow of air that can be inhaled and exhaled.
Related Links:
Cognita Labs
The Cognita Labs (Santa Ana, CA, USA) CapMedic device is a wireless AI-powered sensor cap that can be attached to any MDI, in order to provide precisely timed, step-by-step interactive cues that break down complex inhalation steps. Examples of such audiovisual cues include the correct coordination of deep inhalation, and even easy-to-forget preliminary steps such as shaking the MDI before use and maintaining it in an upright position. Indications for use include asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary conditions.
CapMedic is also a dual-purpose device, thanks to an in-built spirometer that empowers users to track the progression of their lung health by measuring lung parameters such as forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF). Medication and lung function data can be transferred to the CapMedic smartphone app, empowering patients to actively engage in managing their condition and enabling remote patient monitoring (RPM) for providers.
“Decades of studies have shown that almost 90% of patients are unable to use MDIs correctly, a result of their complex, multi-step usage requirements. The Cognita team has conducted drug deposition studies showing a tenfold improvement in the delivery of medication,” said Rajoshi Biswas, PhD, chief scientific officer and co-founder of Cognita Labs. “Our goal with CapMedic is to make inhalers fun and easy to use, while allowing patients to build good inhaler use habits and better manage their respiratory conditions. An effective daily dose means patients are more likely to avoid costly, life-threatening hospitalizations.”
“We've never really known if our patients are getting the medication they need at home because many of them struggle to use inhalers correctly. CapMedic brings us the data we didn't have before,” said pediatric pulmonologist Chris Landon, MD, of the Pediatric Diagnostic Center (Ventura, CA, USA). “We have seen our little patients, and our big ones, loving the sounds and lights of CapMedic while improving their technique. Parents synchronize lung function and medication data with their smartphone app, which gives us a snapshot of their compliance remotely.”
Spirometry is the most common pulmonary function test that measures lung function, specifically the volume and/or flow of air that can be inhaled and exhaled.
Related Links:
Cognita Labs
Latest Critical Care News
- ‘Radar Stethoscope’ Paves Way for Contactless Medical Monitoring
- Database Analysis Helps Identify “Sweet Spot” for Safe Surgery after Heart Attack
- First-In-Kind Flowable Collagen Liquid Fills Tissue Defects and Voids
- Wearable Sensor Patch Paired to Smartphone Detects Arrhythmia
- Early Surgery Aids Elderly Heart Patients with Aortic Stenosis, Finds Study
- AI Provides Same-Day Prediction of Bloodstream Infection and Antimicrobial Resistance in ICU Patients
- Cutting-Edge Bioelectronic Device Offers Drug-Free Approach to Managing Bacterial Infections
- Early TAVR Benefits Patients with Asymptomatic Severe Aortic Stenosis
- Sophisticated Machine-Learning Approach Uses Patient EHRs to Predict Pneumonia Outcomes
- First-Of-Its-Kind Experimental Therapy Enhances Tissue Repair After Heart Attack
- AI Model Predicts Patients at Most Risk of Complication During Treatment for Advanced Kidney Failure
- AI Model Predicts Patients’ Risk of Developing and Worsening Disease from ECGs
- Grain-Sized Soft Robots Controlled by Magnetic Fields Deliver Medical Drugs
- AI Tool Helps Identify Heart Failure Risk in Diabetes Patients
- Inflammation Reducing Antibody Could Serve as Cardio-Immunotherapy for Heart Failure Patients
- AI Tool Accurately Identifies Patients Who Could Require Emergency Hospital Admission